ESR2 and pachyonychia congenita: Additionally, co-expression of ERβ2 and ERβ5, two isoforms of ERβ, represents a prognostic marker for biochemical relapse, postoperative metastasis, and time to metastasize after radical prostatectomy in PC patients (11).